136,900 Shares in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Bought by Bastion Asset Management Inc.

Bastion Asset Management Inc. purchased a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 136,900 shares of the medical instruments supplier's stock, valued at approximately $2,654,000. DENTSPLY SIRONA comprises about 1.7% of Bastion Asset Management Inc.'s holdings, making the stock its 26th largest holding. Bastion Asset Management Inc. owned approximately 0.07% of DENTSPLY SIRONA as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Nordea Investment Management AB boosted its stake in DENTSPLY SIRONA by 245.0% during the 4th quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier's stock valued at $4,754,000 after purchasing an additional 178,639 shares during the period. JPMorgan Chase & Co. raised its holdings in DENTSPLY SIRONA by 206.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock valued at $49,990,000 after acquiring an additional 1,244,326 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in shares of DENTSPLY SIRONA by 27.9% during the 4th quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier's stock worth $45,611,000 after purchasing an additional 523,692 shares in the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of DENTSPLY SIRONA by 1.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier's stock valued at $39,880,000 after purchasing an additional 35,360 shares in the last quarter. Finally, Barclays PLC increased its holdings in DENTSPLY SIRONA by 21.8% in the 3rd quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier's stock valued at $8,301,000 after buying an additional 54,920 shares during the period. Institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Trading Down 0.5 %

Shares of DENTSPLY SIRONA stock traded down $0.08 on Friday, hitting $15.83. 2,379,921 shares of the company's stock traded hands, compared to its average volume of 2,977,101. The firm's 50-day moving average price is $14.36 and its two-hundred day moving average price is $17.69. The stock has a market capitalization of $3.15 billion, a PE ratio of -7.65, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. DENTSPLY SIRONA Inc. has a one year low of $12.16 and a one year high of $28.69.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, beating the consensus estimate of $0.29 by $0.14. The firm had revenue of $879.00 million during the quarter, compared to the consensus estimate of $854.75 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business's quarterly revenue was down 7.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.42 earnings per share. On average, research analysts expect that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were given a $0.16 dividend. The ex-dividend date was Friday, March 28th. This represents a $0.64 annualized dividend and a dividend yield of 4.04%. DENTSPLY SIRONA's dividend payout ratio is presently -14.07%.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the company. Piper Sandler cut their target price on DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a research report on Wednesday, April 30th. Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating and dropped their price objective for the stock from $30.00 to $20.00 in a report on Thursday, January 23rd. Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Wells Fargo & Company cut their price objective on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a research report on Friday, February 28th. Finally, Robert W. Baird lowered their target price on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a research note on Friday, February 28th. Twelve equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $20.45.

Insiders Place Their Bets

In related news, Director Gregory T. Lucier acquired 15,142 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The shares were acquired at an average cost of $16.51 per share, with a total value of $249,994.42. Following the transaction, the director now owns 81,971 shares of the company's stock, valued at $1,353,341.21. The trade was a 22.66 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.52% of the company's stock.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.